0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cyclopentolate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-5T8341
Home | Market Reports | Health| Vision Care
Global Cyclopentolate Market Insights Forecast to 2028
BUY CHAPTERS

Cyclopentolate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5T8341
Report
November 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cyclopentolate - Market Size

The global market for Cyclopentolate was estimated to be worth US$ 1142 million in 2023 and is forecast to a readjusted size of US$ 1551 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030

Cyclopentolate - Market

Cyclopentolate - Market

Cyclopentolate is a muscarinic antagonist. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing or accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclopentolate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cyclopentolate by region & country, by Type, and by Application.
The Cyclopentolate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclopentolate.
Market Segmentation

Scope of Cyclopentolate - Market Report

Report Metric Details
Report Name Cyclopentolate - Market
Forecasted market size in 2030 US$ 1551 million
CAGR 4.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Patent
  • Generic
Segment by Application
  • Mydriatic Agent
  • Muscarinic Receptor Antagonist
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alcon, Novartis, Laboratório Edol, Cadila Healthcare, FDC, Dr. Gerhard Mann, Abdi Ibrahim, Laboratorios Sophia, Bausch and Lomb, Santen, Riemser Arzneimittel, Teva, Akorn
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cyclopentolate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Cyclopentolate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Cyclopentolate in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Cyclopentolate - Market size in 2030?

Ans: The Cyclopentolate - Market size in 2030 will be US$ 1551 million.

Who are the main players in the Cyclopentolate - Market report?

Ans: The main players in the Cyclopentolate - Market are Alcon, Novartis, Laboratório Edol, Cadila Healthcare, FDC, Dr. Gerhard Mann, Abdi Ibrahim, Laboratorios Sophia, Bausch and Lomb, Santen, Riemser Arzneimittel, Teva, Akorn

What are the Application segmentation covered in the Cyclopentolate - Market report?

Ans: The Applications covered in the Cyclopentolate - Market report are Mydriatic Agent, Muscarinic Receptor Antagonist

What are the Type segmentation covered in the Cyclopentolate - Market report?

Ans: The Types covered in the Cyclopentolate - Market report are Patent, Generic

1 Market Overview
1.1 Cyclopentolate Product Introduction
1.2 Global Cyclopentolate Market Size Forecast
1.2.1 Global Cyclopentolate Sales Value (2019-2030)
1.2.2 Global Cyclopentolate Sales Volume (2019-2030)
1.2.3 Global Cyclopentolate Sales Price (2019-2030)
1.3 Cyclopentolate Market Trends & Drivers
1.3.1 Cyclopentolate Industry Trends
1.3.2 Cyclopentolate Market Drivers & Opportunity
1.3.3 Cyclopentolate Market Challenges
1.3.4 Cyclopentolate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cyclopentolate Players Revenue Ranking (2023)
2.2 Global Cyclopentolate Revenue by Company (2019-2024)
2.3 Global Cyclopentolate Players Sales Volume Ranking (2023)
2.4 Global Cyclopentolate Sales Volume by Company Players (2019-2024)
2.5 Global Cyclopentolate Average Price by Company (2019-2024)
2.6 Key Manufacturers Cyclopentolate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cyclopentolate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cyclopentolate
2.9 Cyclopentolate Market Competitive Analysis
2.9.1 Cyclopentolate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cyclopentolate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclopentolate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Patent
3.1.2 Generic
3.2 Global Cyclopentolate Sales Value by Type
3.2.1 Global Cyclopentolate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cyclopentolate Sales Value, by Type (2019-2030)
3.2.3 Global Cyclopentolate Sales Value, by Type (%) (2019-2030)
3.3 Global Cyclopentolate Sales Volume by Type
3.3.1 Global Cyclopentolate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cyclopentolate Sales Volume, by Type (2019-2030)
3.3.3 Global Cyclopentolate Sales Volume, by Type (%) (2019-2030)
3.4 Global Cyclopentolate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mydriatic Agent
4.1.2 Muscarinic Receptor Antagonist
4.2 Global Cyclopentolate Sales Value by Application
4.2.1 Global Cyclopentolate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cyclopentolate Sales Value, by Application (2019-2030)
4.2.3 Global Cyclopentolate Sales Value, by Application (%) (2019-2030)
4.3 Global Cyclopentolate Sales Volume by Application
4.3.1 Global Cyclopentolate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cyclopentolate Sales Volume, by Application (2019-2030)
4.3.3 Global Cyclopentolate Sales Volume, by Application (%) (2019-2030)
4.4 Global Cyclopentolate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cyclopentolate Sales Value by Region
5.1.1 Global Cyclopentolate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cyclopentolate Sales Value by Region (2019-2024)
5.1.3 Global Cyclopentolate Sales Value by Region (2025-2030)
5.1.4 Global Cyclopentolate Sales Value by Region (%), (2019-2030)
5.2 Global Cyclopentolate Sales Volume by Region
5.2.1 Global Cyclopentolate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cyclopentolate Sales Volume by Region (2019-2024)
5.2.3 Global Cyclopentolate Sales Volume by Region (2025-2030)
5.2.4 Global Cyclopentolate Sales Volume by Region (%), (2019-2030)
5.3 Global Cyclopentolate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cyclopentolate Sales Value, 2019-2030
5.4.2 North America Cyclopentolate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cyclopentolate Sales Value, 2019-2030
5.5.2 Europe Cyclopentolate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cyclopentolate Sales Value, 2019-2030
5.6.2 Asia Pacific Cyclopentolate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cyclopentolate Sales Value, 2019-2030
5.7.2 South America Cyclopentolate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cyclopentolate Sales Value, 2019-2030
5.8.2 Middle East & Africa Cyclopentolate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cyclopentolate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cyclopentolate Sales Value
6.2.1 Key Countries/Regions Cyclopentolate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cyclopentolate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cyclopentolate Sales Value, 2019-2030
6.3.2 United States Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cyclopentolate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cyclopentolate Sales Value, 2019-2030
6.4.2 Europe Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cyclopentolate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cyclopentolate Sales Value, 2019-2030
6.5.2 China Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cyclopentolate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cyclopentolate Sales Value, 2019-2030
6.6.2 Japan Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cyclopentolate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cyclopentolate Sales Value, 2019-2030
6.7.2 South Korea Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cyclopentolate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cyclopentolate Sales Value, 2019-2030
6.8.2 Southeast Asia Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cyclopentolate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cyclopentolate Sales Value, 2019-2030
6.9.2 India Cyclopentolate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cyclopentolate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alcon
7.1.1 Alcon Company Information
7.1.2 Alcon Introduction and Business Overview
7.1.3 Alcon Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Alcon Cyclopentolate Product Offerings
7.1.5 Alcon Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Introduction and Business Overview
7.2.3 Novartis Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis Cyclopentolate Product Offerings
7.2.5 Novartis Recent Development
7.3 Laboratório Edol
7.3.1 Laboratório Edol Company Information
7.3.2 Laboratório Edol Introduction and Business Overview
7.3.3 Laboratório Edol Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Laboratório Edol Cyclopentolate Product Offerings
7.3.5 Laboratório Edol Recent Development
7.4 Cadila Healthcare
7.4.1 Cadila Healthcare Company Information
7.4.2 Cadila Healthcare Introduction and Business Overview
7.4.3 Cadila Healthcare Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cadila Healthcare Cyclopentolate Product Offerings
7.4.5 Cadila Healthcare Recent Development
7.5 FDC
7.5.1 FDC Company Information
7.5.2 FDC Introduction and Business Overview
7.5.3 FDC Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 FDC Cyclopentolate Product Offerings
7.5.5 FDC Recent Development
7.6 Dr. Gerhard Mann
7.6.1 Dr. Gerhard Mann Company Information
7.6.2 Dr. Gerhard Mann Introduction and Business Overview
7.6.3 Dr. Gerhard Mann Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Dr. Gerhard Mann Cyclopentolate Product Offerings
7.6.5 Dr. Gerhard Mann Recent Development
7.7 Abdi Ibrahim
7.7.1 Abdi Ibrahim Company Information
7.7.2 Abdi Ibrahim Introduction and Business Overview
7.7.3 Abdi Ibrahim Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Abdi Ibrahim Cyclopentolate Product Offerings
7.7.5 Abdi Ibrahim Recent Development
7.8 Laboratorios Sophia
7.8.1 Laboratorios Sophia Company Information
7.8.2 Laboratorios Sophia Introduction and Business Overview
7.8.3 Laboratorios Sophia Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Laboratorios Sophia Cyclopentolate Product Offerings
7.8.5 Laboratorios Sophia Recent Development
7.9 Bausch and Lomb
7.9.1 Bausch and Lomb Company Information
7.9.2 Bausch and Lomb Introduction and Business Overview
7.9.3 Bausch and Lomb Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bausch and Lomb Cyclopentolate Product Offerings
7.9.5 Bausch and Lomb Recent Development
7.10 Santen
7.10.1 Santen Company Information
7.10.2 Santen Introduction and Business Overview
7.10.3 Santen Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Santen Cyclopentolate Product Offerings
7.10.5 Santen Recent Development
7.11 Riemser Arzneimittel
7.11.1 Riemser Arzneimittel Company Information
7.11.2 Riemser Arzneimittel Introduction and Business Overview
7.11.3 Riemser Arzneimittel Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Riemser Arzneimittel Cyclopentolate Product Offerings
7.11.5 Riemser Arzneimittel Recent Development
7.12 Teva
7.12.1 Teva Company Information
7.12.2 Teva Introduction and Business Overview
7.12.3 Teva Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Teva Cyclopentolate Product Offerings
7.12.5 Teva Recent Development
7.13 Akorn
7.13.1 Akorn Company Information
7.13.2 Akorn Introduction and Business Overview
7.13.3 Akorn Cyclopentolate Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Akorn Cyclopentolate Product Offerings
7.13.5 Akorn Recent Development
8 Industry Chain Analysis
8.1 Cyclopentolate Industrial Chain
8.2 Cyclopentolate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cyclopentolate Sales Model
8.5.2 Sales Channel
8.5.3 Cyclopentolate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cyclopentolate Market Trends
    Table 2. Cyclopentolate Market Drivers & Opportunity
    Table 3. Cyclopentolate Market Challenges
    Table 4. Cyclopentolate Market Restraints
    Table 5. Global Cyclopentolate Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cyclopentolate Revenue Market Share by Company (2019-2024)
    Table 7. Global Cyclopentolate Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Cyclopentolate Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Cyclopentolate Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Cyclopentolate Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Cyclopentolate Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Cyclopentolate
    Table 13. Global Cyclopentolate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclopentolate as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Cyclopentolate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Cyclopentolate Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Cyclopentolate Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Cyclopentolate Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Cyclopentolate Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Cyclopentolate Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Cyclopentolate Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Cyclopentolate Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Cyclopentolate Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Cyclopentolate Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Cyclopentolate Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Cyclopentolate Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Cyclopentolate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Cyclopentolate Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Cyclopentolate Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Cyclopentolate Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Cyclopentolate Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Cyclopentolate Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Cyclopentolate Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Cyclopentolate Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Cyclopentolate Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Cyclopentolate Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Cyclopentolate Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Cyclopentolate Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Cyclopentolate Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Cyclopentolate Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Cyclopentolate Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Cyclopentolate Sales Value by Region (2019-2024) & (%)
    Table 44. Global Cyclopentolate Sales Value by Region (2025-2030) & (%)
    Table 45. Global Cyclopentolate Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Cyclopentolate Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Cyclopentolate Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Cyclopentolate Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Cyclopentolate Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Cyclopentolate Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Cyclopentolate Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Cyclopentolate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Cyclopentolate Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Cyclopentolate Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Cyclopentolate Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Cyclopentolate Sales Volume, (2025-2030) & (K Units)
    Table 57. Alcon Company Information
    Table 58. Alcon Introduction and Business Overview
    Table 59. Alcon Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Alcon Cyclopentolate Product Offerings
    Table 61. Alcon Recent Development
    Table 62. Novartis Company Information
    Table 63. Novartis Introduction and Business Overview
    Table 64. Novartis Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Novartis Cyclopentolate Product Offerings
    Table 66. Novartis Recent Development
    Table 67. Laboratório Edol Company Information
    Table 68. Laboratório Edol Introduction and Business Overview
    Table 69. Laboratório Edol Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Laboratório Edol Cyclopentolate Product Offerings
    Table 71. Laboratório Edol Recent Development
    Table 72. Cadila Healthcare Company Information
    Table 73. Cadila Healthcare Introduction and Business Overview
    Table 74. Cadila Healthcare Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Cadila Healthcare Cyclopentolate Product Offerings
    Table 76. Cadila Healthcare Recent Development
    Table 77. FDC Company Information
    Table 78. FDC Introduction and Business Overview
    Table 79. FDC Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. FDC Cyclopentolate Product Offerings
    Table 81. FDC Recent Development
    Table 82. Dr. Gerhard Mann Company Information
    Table 83. Dr. Gerhard Mann Introduction and Business Overview
    Table 84. Dr. Gerhard Mann Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Dr. Gerhard Mann Cyclopentolate Product Offerings
    Table 86. Dr. Gerhard Mann Recent Development
    Table 87. Abdi Ibrahim Company Information
    Table 88. Abdi Ibrahim Introduction and Business Overview
    Table 89. Abdi Ibrahim Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Abdi Ibrahim Cyclopentolate Product Offerings
    Table 91. Abdi Ibrahim Recent Development
    Table 92. Laboratorios Sophia Company Information
    Table 93. Laboratorios Sophia Introduction and Business Overview
    Table 94. Laboratorios Sophia Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Laboratorios Sophia Cyclopentolate Product Offerings
    Table 96. Laboratorios Sophia Recent Development
    Table 97. Bausch and Lomb Company Information
    Table 98. Bausch and Lomb Introduction and Business Overview
    Table 99. Bausch and Lomb Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Bausch and Lomb Cyclopentolate Product Offerings
    Table 101. Bausch and Lomb Recent Development
    Table 102. Santen Company Information
    Table 103. Santen Introduction and Business Overview
    Table 104. Santen Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Santen Cyclopentolate Product Offerings
    Table 106. Santen Recent Development
    Table 107. Riemser Arzneimittel Company Information
    Table 108. Riemser Arzneimittel Introduction and Business Overview
    Table 109. Riemser Arzneimittel Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Riemser Arzneimittel Cyclopentolate Product Offerings
    Table 111. Riemser Arzneimittel Recent Development
    Table 112. Teva Company Information
    Table 113. Teva Introduction and Business Overview
    Table 114. Teva Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Teva Cyclopentolate Product Offerings
    Table 116. Teva Recent Development
    Table 117. Akorn Company Information
    Table 118. Akorn Introduction and Business Overview
    Table 119. Akorn Cyclopentolate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Akorn Cyclopentolate Product Offerings
    Table 121. Akorn Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Cyclopentolate Downstream Customers
    Table 125. Cyclopentolate Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cyclopentolate Product Picture
    Figure 2. Global Cyclopentolate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Cyclopentolate Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Cyclopentolate Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Cyclopentolate Report Years Considered
    Figure 7. Global Cyclopentolate Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Cyclopentolate Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cyclopentolate Revenue in 2023
    Figure 10. Cyclopentolate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Patent Picture
    Figure 12. Generic Picture
    Figure 13. Global Cyclopentolate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Cyclopentolate Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Cyclopentolate Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Cyclopentolate Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Cyclopentolate Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Mydriatic Agent
    Figure 19. Product Picture of Muscarinic Receptor Antagonist
    Figure 20. Global Cyclopentolate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Cyclopentolate Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Cyclopentolate Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Cyclopentolate Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Cyclopentolate Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Cyclopentolate Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Cyclopentolate Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Cyclopentolate Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Cyclopentolate Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Cyclopentolate Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Cyclopentolate Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Cyclopentolate Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Cyclopentolate Sales Volume (%), (2019-2030)
    Figure 37. United States Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Cyclopentolate Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Cyclopentolate Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Cyclopentolate Sales Value by Application (%), 2023 VS 2030
    Figure 58. Cyclopentolate Industrial Chain
    Figure 59. Cyclopentolate Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Disposable Medical Protective Wear Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-24Q7462
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Add to Cart

Comprehensive Ophthalmology Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-3X18805
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global 3-Ply Medical Surgical Mask Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-3N7947
Thu Dec 12 00:00:00 UTC 2024

Add to Cart